![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Healthcare Ent. | LSE:HCEG | London | Ordinary Share | GB00B6030H73 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:3339U Healthcare Enterprise Group PLC 16 January 2004 Healthcare Enterprise Group PLC Changes in directorships Healthcare Enterprise Group PLC ("HCEG") announces the resignation today of Anthony Moore as a non-executive director of both HCEG and of HCEG's subsidiary, Healthcare Enterprise Group, Inc. ("HCEGI") and the appointment of Kenneth Denos, General Counsel to HCEG, as an executive director of HCEG. Messrs. Moore and Denos are both directors of Moore, Clayton & Co., Inc. ("MCC"), a global strategic and financial advisory services firm headquartered in the United States. MCC was a founding shareholder of HCEGI, which was acquired by HCEG in March 2003. Mr. Moore's resignation and Mr. Denos' appointment are part of a transition of Mr. Moore's increased duties within MCC as its Co-Chairman and CEO. Kenneth Ian Denos, aged 35, is a practising lawyer and has served as General Counsel to HCEG since the acquisition of HCEGI and as General Counsel of HCEGI since its inception. Mr. Denos' practice areas have included public and private corporate finance, mergers and acquisitions, licensing and joint venture agreements, and technology commercialisation. He joins the HCEG Board with a background which includes executive level experience in venture capital and emerging growth companies in the UK and the US. Mr. Denos is also a member of the Board of Directors of Morphogenesis, Inc., a US-based biotechnology firm. Directorships of Kenneth Denos currently held and held during the five years preceding the date of this announcement are set out at the end of this announcement. Mr. Denos holds options to subscribe for 8,493,448 ordinary shares of 0.1p each in HCEG ("Ordinary Shares") and options to acquire a further 8,493,448 Ordinary Shares from LPMCC, LLC, a principal shareholder in HCEG. HCEG has also been informed by Mr. Denos that he holds a membership interest of approximately 3.5 per cent. in LPMCC. There are no further disclosures to be made in accordance with Rule 15 and schedule 2(f) of the AIM Rules in connection with Kenneth Denos. Ken Denos, General Counsel, Healthcare Enterprise Group, commented: "Healthcare Enterprise Group aims to grow into a substantial business within the healthcare products and services sector. I have been involved with the company since inception and have every confidence that these aims and ambitions will be achieved. "I believe that our target markets present considerable opportunities and look forward to the future with confidence." Mr. Moore stated: "I am delighted, along with my co-founding business partner Sharon Clayton, to have assisted in the formation and development of Healthcare Enterprise Group. I wish the Board and HCEG continued success and progress in the growth and profitability of its world-wide businesses." Stuart Bruck, Chairman, Healthcare Enterprise Group, commented: "Tony Moore and Sharon Clayton have played a valuable part in the formation and development of HCEG. We wish him well for the future. "Ken has been a significant contributor to the company's development over the crucial period during the acquisitions and fund raising last November and the transactions since. He has already demonstrated his entrepreneurial skills in identifying transactional opportunities for the group and we look forward to the continued benefits of these skills and his financial and legal aptitude over coming years." 16 January 2004 Enquiries: Healthcare Enterprise Group PLC Tel: 020 7659 6158 Stuart Bruck, Executive Chairman College Hill Tel: 020 7457 2020 Nicholas Nelson / Corinna Dorward Directorships of Kenneth Denos currently held and held during the five years preceding the date of this announcement are as follows: Current Directorships: HCEGI Moore, Clayton & Co., Inc.and subsidiaries Medical Development Specialists, Inc. SportsNuts, Inc.and subsidiaries The Safa Group Limited Talwar Capital Group,Inc. SafaTec (UK) Limited Kenneth I. Denos, P.C. Morphogenesis, Inc. Digital Finance Corporation, Inc. Digital Finance Corporation Former Directorships: None. This information is provided by RNS The company news service from the London Stock Exchange END BOAGUURCGUPCGWQ
1 Year Healthcare Enterprise Chart |
1 Month Healthcare Enterprise Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions